Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 2/2019

01-06-2019 | Case Report

Salivary Duct Carcinoma of Parotid Gland: a Rare Tumor

Authors: Giridhar Chidananda-Murthy, Jayanthi Chandran

Published in: Indian Journal of Surgical Oncology | Issue 2/2019

Login to get access

Excerpt

Tumors of the salivary gland account for 3–4% of all head and neck malignancies [1]. About 70–90% of these tumors are located in parotid gland of which majority are benign and only 15% are malignant [1]. Mucoepidermoid carcinoma is the most common salivary gland malignancy followed by carcinoma ex-pleomorphic adenoma and acinic cell carcinoma. Other malignant tumors include adenoid cystic carcinoma, adenocarcinoma, squamous cell carcinoma, and poorly differentiated carcinoma [2]. Lymphoma of salivary glands is rare and commonly involves parotid gland. Parotid gland can harbor metastases to intraparotid nodes from tumors involving upper face particularly temple area and external auditory canal. …
Literature
1.
go back to reference Eveson JW, Cawson RA (1985) Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 146(1):51–58CrossRefPubMed Eveson JW, Cawson RA (1985) Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 146(1):51–58CrossRefPubMed
2.
go back to reference Kane WJ, McCaffrey TV, Olsen KD, Lewis JE (1991) Primary parotid malignancies: a clinical and pathologic review. Arch Otolaryngol Head Neck Surg 117(3):307–315CrossRefPubMed Kane WJ, McCaffrey TV, Olsen KD, Lewis JE (1991) Primary parotid malignancies: a clinical and pathologic review. Arch Otolaryngol Head Neck Surg 117(3):307–315CrossRefPubMed
3.
go back to reference Barnes L, Rao U, Krause J, Contis L, Schwartz A, Scalamogna P (1994) Salivary duct carcinoma: part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature. Oral surgery, oral medicine. Oral Pathol 78(1):64–73CrossRef Barnes L, Rao U, Krause J, Contis L, Schwartz A, Scalamogna P (1994) Salivary duct carcinoma: part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature. Oral surgery, oral medicine. Oral Pathol 78(1):64–73CrossRef
4.
go back to reference Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T (2005) Clinical and immunohistologic typing of salivary duct carcinoma. Cancer 103(12):2526–2533CrossRefPubMed Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T (2005) Clinical and immunohistologic typing of salivary duct carcinoma. Cancer 103(12):2526–2533CrossRefPubMed
5.
go back to reference Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD (1996) Salivary duct carcinoma: clinicopathologic and immunohistochemical review of 26 cases. Cancer 77(2):223–230CrossRefPubMed Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD (1996) Salivary duct carcinoma: clinicopathologic and immunohistochemical review of 26 cases. Cancer 77(2):223–230CrossRefPubMed
6.
7.
go back to reference Guzzo M, Palma SD, Grandi C, Molinari R (1997) Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck 19(2):126–133CrossRefPubMed Guzzo M, Palma SD, Grandi C, Molinari R (1997) Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck 19(2):126–133CrossRefPubMed
8.
go back to reference Kleinsasser O (1968) Speichelgang-carcinome, Eine den milchgangcarcinomen der Brustdruse analoge Gruppe von Speicheldrusentumoren. Arch Klin Exp Ohren Nasen Kehlkopfheikd 192:100–105CrossRef Kleinsasser O (1968) Speichelgang-carcinome, Eine den milchgangcarcinomen der Brustdruse analoge Gruppe von Speicheldrusentumoren. Arch Klin Exp Ohren Nasen Kehlkopfheikd 192:100–105CrossRef
9.
go back to reference Lee YY, Wong KT, King AD, Ahuja AT (2008) Imaging of salivary gland tumours. Eur J Radiol 66(3):419–436CrossRefPubMed Lee YY, Wong KT, King AD, Ahuja AT (2008) Imaging of salivary gland tumours. Eur J Radiol 66(3):419–436CrossRefPubMed
10.
11.
go back to reference Motoori K, Iida Y, Nagai Y, Yamamoto S, Ueda T, Funatsu H, Ito H, Yoshitaka O (2005) MR imaging of salivary duct carcinoma. Am J Neuroradiol 26(5):1201–1206PubMedPubMedCentral Motoori K, Iida Y, Nagai Y, Yamamoto S, Ueda T, Funatsu H, Ito H, Yoshitaka O (2005) MR imaging of salivary duct carcinoma. Am J Neuroradiol 26(5):1201–1206PubMedPubMedCentral
12.
go back to reference O'Dwyer P, Farrar WB, James AG, Finkelmeier W, McCabe DP (1986) Needle aspiration biopsy of major salivary gland tumors: its value. Cancer 57(3):554–557CrossRefPubMed O'Dwyer P, Farrar WB, James AG, Finkelmeier W, McCabe DP (1986) Needle aspiration biopsy of major salivary gland tumors: its value. Cancer 57(3):554–557CrossRefPubMed
13.
go back to reference Skalova A, Starek I, Vanecek T, Kucerova V, Plank L, Szepe P, Di Palma S, Leivo I (2003) Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology 42(4):348–356CrossRefPubMed Skalova A, Starek I, Vanecek T, Kucerova V, Plank L, Szepe P, Di Palma S, Leivo I (2003) Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology 42(4):348–356CrossRefPubMed
14.
go back to reference Hosal AS, Fan C, Barnes L, Myers EN (2003) Salivary duct carcinoma. Otolaryngol Head Neck Surg 129(6):720–725CrossRefPubMed Hosal AS, Fan C, Barnes L, Myers EN (2003) Salivary duct carcinoma. Otolaryngol Head Neck Surg 129(6):720–725CrossRefPubMed
15.
go back to reference Nasser SM, Faquin WC, Dayal Y (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors: frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 119(6):801–806CrossRefPubMed Nasser SM, Faquin WC, Dayal Y (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors: frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 119(6):801–806CrossRefPubMed
16.
go back to reference Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS (2007) Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy. Head Neck 29(10):907–912CrossRefPubMed Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS (2007) Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy. Head Neck 29(10):907–912CrossRefPubMed
17.
go back to reference Limaye SA, Posner MR, Krane JF, Fonfria M, Lorch JH, Dillon DA, Shreenivas AV, Tishler RB, Haddad RI (2013) Trastuzumab for the treatment of salivary duct carcinoma. Oncologist 18(3):294–300CrossRefPubMedPubMedCentral Limaye SA, Posner MR, Krane JF, Fonfria M, Lorch JH, Dillon DA, Shreenivas AV, Tishler RB, Haddad RI (2013) Trastuzumab for the treatment of salivary duct carcinoma. Oncologist 18(3):294–300CrossRefPubMedPubMedCentral
18.
go back to reference Kapadia SB, Barnes L (1998) Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol 11(11):1033–1038PubMed Kapadia SB, Barnes L (1998) Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol 11(11):1033–1038PubMed
19.
go back to reference Fan CY, Wang J, Barnes EL (2000) Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol 24(4):579–586CrossRefPubMed Fan CY, Wang J, Barnes EL (2000) Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol 24(4):579–586CrossRefPubMed
20.
go back to reference Simpson RH (2013) Salivary duct carcinoma: new developments—morphological variants including pure in situ high grade lesions; proposed molecular classification. Head and Neck Pathology 7(1):48–58CrossRefPubMedCentral Simpson RH (2013) Salivary duct carcinoma: new developments—morphological variants including pure in situ high grade lesions; proposed molecular classification. Head and Neck Pathology 7(1):48–58CrossRefPubMedCentral
21.
go back to reference Gnepp DR (1991) Metastatic disease to the major salivary gland. In: Ellis GL, Auclair PL, Gnepp DR (ed) Surgical pathology of the salivary glands, 1st edn. WB Saunders, Philadelphia, pp 560–569 Gnepp DR (1991) Metastatic disease to the major salivary gland. In: Ellis GL, Auclair PL, Gnepp DR (ed) Surgical pathology of the salivary glands, 1st edn. WB Saunders, Philadelphia, pp 560–569
22.
go back to reference Delgado R, Klimstra D, Albores-Saavedra J (1996) Low grade salivary duct carcinoma: a distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer 78(5):958–967CrossRefPubMed Delgado R, Klimstra D, Albores-Saavedra J (1996) Low grade salivary duct carcinoma: a distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer 78(5):958–967CrossRefPubMed
Metadata
Title
Salivary Duct Carcinoma of Parotid Gland: a Rare Tumor
Authors
Giridhar Chidananda-Murthy
Jayanthi Chandran
Publication date
01-06-2019
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 2/2019
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-018-0853-4

Other articles of this Issue 2/2019

Indian Journal of Surgical Oncology 2/2019 Go to the issue